Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy;Neoadjuvante Therapie der Adenokarzinome des oberen Gastrointestinaltraktes: Rolle der Strahlentherapie

Chirurg

Volumn 80, Issue 11, 2009, Pages 1035-1041

  Semrau, R ^a   Vallbohmer D ^a   Holscher A H ^a   Muller R P ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Radiotherapy Esophageal cancer Gastric cancer Chemotherapy Review

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; ESOPHAGUS TUMOR; HUMAN; LYMPH NODE METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS;

EID: 70449524568     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-009-1737-5     Document Type: Article

References (45)

1. Urschel JD, Vasan H (2003) A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 185(6):538-543
2. Kaklamanos IG, Walker GR, Ferry K et al (2003) Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 10(7):754-761
3. Fiorica F, Di Bona D, Schepis F et al (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53(7):925-930
4. Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R (2006) Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 78(3):236-244
5. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8(3):226-234
6. Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surg ry for esophageal adenocarcinoma. N Engl J Med 335(7):462-467
7. Stahl M, Walz MK, Stuschke M et al (2009) Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27(6):851-856
8. . Arnott SJ, Duncan W, Gignoux M et al (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev (4):CD001799
9. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11-20
10. Zhang ZX, Gu XZ, Yin WB et al (1998) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients. Int J Radiat Oncol Biol Phys 42(5):929-934
11. Fiorica F, Cartei F, Enea M et al (2007) The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev 33(8):729-740
12. Janunger KG, Hafstrom L, Glimelius B (2002) Che- motherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 168(11):597-608
13. Hermans J, Bonenkamp JJ, Boon MC et al (1993) Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11(8):1441-1447
14. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345(10):725-730
15. Schwartz GK, Winter K, Minsky BD et al (2009) Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric can- cer (RTOG-0114). J Clin Oncol 27(12):1956-1962
16. Chang F, Deere H, Mahadeva U, George S (2008) Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and cur- rent issues. Am J Clin Pathol 129(2):252-262
17. Schneider PM, Baldus SE, Metzger R et al (2005) Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 242(5):684-692
18. Ott K, Weber WA, Lordick F et al (2006) Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24(29):4692-4698
19. Vallbohmer D, Holscher AH, Schmidt M et al (2008) Limitations of positron emission tomography in predicting histopathologic response or prognosis following neoadjuvant chemoradiation for eso- phageal cancer. J Clin Oncol (Meeting Abstracts) 26 [Suppl 15]:4529
20. Vallbohmer D, Lenz HJ (2006) Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 19(6):425-432
21. Bollschweiler E, Metzger R, Drebber U et al (2009) Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 20(2):231-238
22. van Meerten E, van der Gaast A, Tilanus HW et al (2009) Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: The Rotterdam experience. J Surg Oncol 100:32-37
23. Rice TW, Blackstone EH, Adelstein DJ et al (2001) N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg 121(3):454-464
24. Wang SL, Liao Z, Vaporciyan AA et al (2006) Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-699
25. Ruhstaller T, Widmer L, Schuller JC et al (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Ann Oncol 20:1522-1528
26. Roof KS, Coen J, Lynch TJ et al (2006) Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 65(4):1120-1128
27. Ilson DH, Bains M, Kelsen DP et al (2003) Pha- se I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer. J Clin Oncol 21(15):2926-2932
28. Michel P, Adenis A, Di Fiore F et al (2006) Induction cisplatin-irinotecan followed by concurrent cispla- tin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Br J Cancer 95(6):705-709
29. Kleinberg L, Powell ME, Forastiere A et al (2007) E1201: An Eastern Cooperative Oncology Group (ECOG) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/RT or irinotecan/ cisplatin/RT in endoscopy with ultrasound (EUS) staged adenocarcinoma of the esophagus. J Clin Oncol (Meeting Abstracts) 25 [Suppl 18]:4533
30. Safran H, Suntharalingam M, Dipetrillo T et al (2008) Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. Int J Radiat Oncol Biol Phys 70(2):391-395
31. RTOG 0436 (2008) A phase III trial. Evaluating the addition of cetuximab to paclitaxel cisplatin, and radiation for patients with esophageal cancer who are treated without surgery. http://www.rtog.org/members/protocols/0436/0436.pdf accessed 27.09.09
32. Vallbohmer D, Drebber U, Schneider PM et al (2009) Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol 99(7):409-413
33. Alakus H, Warnecke-Eberz U, Bollschweiler E et al (2009) GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer. Pharmacogenomics J 9(3):202-207
34. Warnecke-Eberz U, Vallbohmer D, Alakus H et al (2009) ERCC1 and XRCC1 Gene Polymorphisms Predict Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer. J Gastrointest Surg 13:1411-1421
35. Nygaard K, Hagen S, Hansen HS et al (1992) Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16(6):1104-1110
36. Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 41(4):391-393
37. Le Prise E, Etienne PL, Meunier B et al (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73(7):1779-1784
38. Urba SG, Orringer MB, Turrisi A et al (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19(2):305-313
39. Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337(3):161-167
40. Burmeister BH, Smithers BM, Gebski V et al (2005) Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 6(9):659-668
41. Tepper JE, Krasna M, Niedzwiecki D et al (2006) Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781. J Clin Oncol (Meeting Abstracts) 24 [Suppl 18]:4012
42. Lee JL, Park SI, Kim SB et al (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15(6):947-954
43. Medical Research Council Oesophageal Cancer Working Group (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359(9319):1727-1733
44. Kelsen DP, Ginsberg R, Pajak TF et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339(27):1979-1984
45. Kelsen DP, Winter KA, Gunderson LL et al (2007) Long-Term Results of RTOG Trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25(24):3719-3725